Sensei Biotherapeutics, Inc.
ASPARTATE BETA-HYDROXYLASE CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
Last updated:
Abstract:
Provided herein are anti-ASPH chimeric antigen receptors (CARs), genetically modified immune effector cells, and use of these compositions to effectively treat ASPH expressing cancers.
Status:
Application
Type:
Utility
Filling date:
10 May 2019
Issue date:
14 Nov 2019